Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00870818 · ClinicalTrials.gov registry record · NA
Protege Extension Trial - Long Term Follow Up Trial for Subjects Who Completed the Protege Study (CP-MGA031-01)
A NA study, sponsored by MacroGenics.
- Terminated
- Registry status
- NA
- Development phase
- 219
- Enrollment target
NCT00870818: Clinical Trial NA study, sponsored by MacroGenics.
NCT00870818 is a NA study that was terminated before completion, run by MacroGenics. The registered enrollment target is 219 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00870818, a NA study, was terminated before completion, sponsored by MacroGenics.
- TERMINATED
- Registry status
- NA
- Development phase
- 219 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the long term safety and efficacy in subjects with Type 1 Diabetes Mellitus who completed the Protege Study (CP-MGA031-01).
Interventions
- DIAGNOSTIC_TEST Blood samples for safety
- BEHAVIORAL Patient reported outcome questionnaires
- DIAGNOSTIC_TEST Analysis of T-cell subsets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 219 participants |
| Start Date | 2009-02 |
| Est. Completion | 2011-05 |
| Phase | NA |
Why NCT00870818 stopped before completion
NCT00870818 is an interventional study that assigns participants to a tested intervention. The registered 219 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).
The record links to 0 conditions, and to 3 interventions - of which Blood samples for safety is the first listed.
NCT00870818 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00870818 about?
NCT00870818 is a clinical study titled "Protege Extension Trial - Long Term Follow Up Trial for Subjects Who Completed the Protege Study (CP-MGA031-01)". The purpose of this study is to assess the long term safety and efficacy in subjects with Type 1 Diabetes Mellitus who completed the Protege Study (CP-MGA031-01).
What is the current status of trial NCT00870818?
This trial is currently terminated. It is a NA study. The enrollment target is 219 participants. The study started on 2009-02. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00870818?
The interventions under investigation include: Blood samples for safety (DIAGNOSTIC_TEST), Patient reported outcome questionnaires (BEHAVIORAL), Analysis of T-cell subsets (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT00870818?
This trial is sponsored by MacroGenics, which has 36 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00870818's enrollment target sits among peer trials
219 485th of 2000 higher than 1,516 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05196035 · 219 participants · Phase 3
A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria
- NCT05608434 · 219 participants · Phase 1
Development of Virtual Reality-based Interventions to Strengthen Cognitive Skillsets Related to Attention Deficit Hyperactivity Disorder (ADHD): A Pilot Phase I and Randomized Controlled Phase II Trial
- NCT05773144 · 219 participants · NA
Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer
- NCT05907980 · 219 participants · Phase 1
A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia